推薦產品
生物源
synthetic
等級
pharmaceutical primary standard
agency
USP
API 家族
famotidine
形狀
powder
包裝
pkg of 25 mg
製造商/商標名
USP
儲存條件
protect from light
顏色
white
應用
pharmaceutical (small molecule)
格式
neat
儲存溫度
2-8°C
InChI
1S/C10H14N8S4/c11-7(12)17-9-15-5(1-19-9)3-21-22-4-6-2-20-10(16-6)18-8(13)14/h1-2H,3-4H2,(H4,11,12,15,17)(H4,13,14,16,18)
InChI 密鑰
ZWHJVLVEEDAPHN-UHFFFAOYSA-N
尋找類似的產品? 前往 產品比較指南
一般說明
Famotidine Related Compound E (Famotidine Impurity E) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
應用
Famotidine Related Compound E can be used as a pharmaceutical primary standard for the determination of the analyte in pharmaceutical formulations by various analytical techniques.
Also, for use with USP monograph such as Famotidine
Also, for use with USP monograph such as Famotidine
分析報告
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他說明
Sales restrictions may apply.
相關產品
產品號碼
描述
訂價
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
Famotidine
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Potentiometric determination of famotidine in pharmaceutical formulations
Journal of Pharmaceutical and Biomedical Analysis, 29(1-2) (2002)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Chromatographia, 60(7-8) (2004)
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務